---
$id: https://graph.org.ai/products/commodity/51161517
$type: Product
source: UNSPSC
code: "51161517"
title: "Zileuton"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zileuton

**UNSPSC Code**: 51161517
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lipooxygenase inhibitor with the molecular formula C11H12N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1L22WVE2S, chemically known as urea, n-(1-benzo(b)thien-2-ylethyl)-n-hydroxy- but generally known as zileuton, which bears US NIH Compound Identifier 60490. European Medicines Agency schedules Zileuton in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00157MIG. The term ZILEUTON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). ZILEUTON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zileuton under HS 29349990 and SITC 51579. As of Q4 2014, ZILEUTON remains the US FDA Preferred Term for this commodity. Zileuton bears US NLM identifiers UMLS ID C0081408 and NCI Concept Code C26667. SMILES: CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O.

